Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men

Journal of Bone and Mineral Research

Volumn 22, Issue 2, 2007, Pages 220-227

  Vandenput, Liesbeth ^a   Labrie, Fernand ^b   Mellström, Dan ^a   Swanson, Charlotte ^a   Knutsson, Thomas ^c   Peeker, Ralph ^c   Ljunggren, Östen ^d   Orwoll, Eric ^e   Eriksson, Anna L ^a   Damber, Jan Erik ^c   Ohlsson, Claes ^a,f  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Androgen metabolites; Bone; Population studies; Prostate; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANE 3ALPHA,17BETA DIOL 17 GLUCURONIDE; ANDROSTANE 3ALPHA,17BETA DIOL 3 GLUCURONIDE; ANDROSTANOLONE; TESTOSTERONE; UNCLASSIFIED DRUG;

AGED; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; ANDROGEN SYNTHESIS; ANDROGENESIS; ARTICLE; BONE DENSITY; DEGRADATION; DUAL ENERGY X RAY ABSORPTIOMETRY; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; ORGAN SIZE; PROSTATE CANCER; PROSTATE VOLUME; SWEDEN; TESTOSTERONE BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY;

AGED; ANDROGENS; BONE DENSITY; CHROMATOGRAPHY, LIQUID; DENSITOMETRY, X-RAY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCURONIDES; HUMANS; MALE; PROSTATE; RADIOIMMUNOASSAY;

EID: 33846470451     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.061018     Document Type: Article

References (43)

1. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C 2004 Androgens and bone. Endocr Rev 25:389-425.
2. Kaufman JM, Vermeulen A 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833-876.
3. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez J, Candas B 2005 Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocr Rev 26:361-379.
4. Zhuang TN, Ly LP, Cumming RG, Handelsman DJ 2005 Growth and development during early manhood as determinants of prostate size in later life. J Clin Endocrinol Metab 90:6055-6063.
5. Labrie F, Dupont A, Belanger A 1985 Complete androgen blockade for the treatment of prostate cancer. In: De Vita VT, Hellman S, Rosenberg SA (eds.) Important Advances in Oncology. JB Lippincot, Philadelphia, PA, USA, pp. 193-217.
6. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC 1997 Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Invest 100:1755-1759.
7. Greendale GA, Edelstein S, Barrett-Connor E 1997 Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study. J Bone Miner Res 12:1833-1843.
8. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266-2274.
9. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseu N, Chailurkit L 1998 Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol (Oxf) 49:803-809.
10. Center JR, Nguyen TV, Sambrook PN, Eisman JA 1999 Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 84:3626-3635.
11. Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, Wilson PWF, Felson DT 2000 Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 133:951-963.
12. Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, Delmas PD 2001 Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study. J Clin Endocrinol Metab 86:192-199.
13. van den Beld AW, De Jong FH, Grobbee DE, Pols HAP, Lamberts SWJ 2000 Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85:3276-3282.
14. Rudman D, Drinka PJ, Wilson CR, Mattson DE, Scherman F, Cuisinier MC, Schultz S 1994 Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol (Oxf) 40:653-661.
15. Murphy S, Khaw KT, Cassidy A, Compston JE 1993 Sex hormones and bone mineral density in elderly men. Bone Miner 20:133-140.
16. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-C118.
17. Labrie C, Belanger A, Labrie F 1988 Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123:1412-1417.
18. Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin SX, Pelletier G 2003 Endocrine and intracrine sources of androgens in women: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 24:152-182.
19. Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S 2003 Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473-479.
20. Labrie F, Belanger A, Cusan L, Candas B 1997 Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: Intracrinology. J Clin Endocrinol Metab 82:2403-2409.
21. Chen W, Thiboutot D, Zouboulis CC 2002 Cutaneous androgen metabolism: Basic research and clinical perspectives. J Invest Dermatol 119:992-1007.
22. Carmina E, Godwin AJ, Stanczyk FZ, Lippman JS, Lobo RA 2002 The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne. J Endocrinol Invest 25:765-768.
23. Rittmaster RS 1993 Androgen conjugates: Physiology and clinical significance. Endocr Rev 14:121-132.
24. Collins GN, Lee RJ, Russell EB, Raab GM, Hehir M 1993 Ultrasonically determined patterns of enlargement in benign prostatic hyperplasia. Br J Urol 71:451-456.
25. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672.
26. Belanger A, Brochu M, Cliche J 1986 Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. J Clin Endocrinol Metab 62:812-815.
27. Poortman J, Thijssen JH, von Landeghem AA, Wiegerinck MA, Alsbach GP 1983 Subcellular distribution of androgens and oestrogens in target tissue. J Steroid Biochem 19:939-945.
28. Belanger B, Belanger A, Labrie F, Dupont A, Cusan L, Monfette G 1989 Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men. J Steroid Biochem 32:695-698.
29. Beaulieu M, Levesque E, Barbier O, Turgeon D, Belanger G, Hum DW, Belanger A 1998 Isolation and characterization of a simian UDP- glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens. J Mol Biol 275:785-794.
30. Beaulieu M, Levesque E, Hum DW, Belanger A 1996 Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855-22862.
31. Carrier JS, Turgeon D, Journault K, Hum DW, Belanger A 2000 Isolation and characterization of the human UGT2B7 gene. Biochem Biophys Res Commun 272:616-621.
32. Coffman BL, Tephly TR, Irshaid YM, Green MD, Smith C, Jackson MR, Wooster R, Burchell B 1990 Characterization and primary sequence of a human hepatic microsomal estriol UDP glucuronosyltransferase. Arch Biochem Biophys 281:170-175.
33. Turgeon D, Carrier JS, Levesque E, Beatty BG, Belanger A, Hum DW 2000 Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489-504.
34. Riggs BL, Khosla S, Melton LJ III 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302.
35. Nilsson LO, Boman A, Savendahl L, Grigelioniene G, Ohlsson C, Ritzen EM, Wroblewski J 1999 Demonstration of estrogen receptor-beta immunoreactivity in human growth plate cartilage. J Clin Endocrinol Metab 84:370-373.
36. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Lowik CW, Pols HA, van Leeuwen JP 1997 Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138:5067-5070.
37. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T 1997 Expression of estrogen receptor beta in rat bone. Endocrinology 138:4509-4512.
38. Vidal O, Kindblom LG, Ohlsson C 1999 Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res 14:923-929.
39. Sims NA, Clement-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M, Baron R 2003 A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest 111:1319-1327.
40. Vidal O, Lindberg MK, Hollberg K, Baylink DJ, Andersson G, Lubahn DB, Mohan S, Gustafsson JA, Ohlsson C 2000 Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci USA 97:5474-5479.
41. Moverare S, Venken K, Eriksson AL, Andersson N, Skrtic S, Wergedal J, Mohan S, Salmon P, Bouillon R, Gustafsson JA, Vanderschueren D, Ohlsson C 2003 Differential effects on bone of estrogen receptor alpha and androgen receptor activation in orchidectomized adult male mice. Proc Natl Acad Sci USA 100:13573-13578.
42. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C 1999 Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 104:895-901.
43. Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C 2006 Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21:529-535.